NCT03940768 is a NA clinical trial of Lactobacillus plantarum 299v in Cancer, sponsored by Medical University of Gdansk.

Who is sponsoring NCT03940768?

NCT03940768 is sponsored by Medical University of Gdansk.

What drugs are being tested in NCT03940768?

Interventions in NCT03940768: Lactobacillus plantarum 299v, Placebo.

Is NCT03940768 still recruiting?

NCT03940768 is currently completed. Last updated 30 March 2020.

Last reviewed 2020-03-30 · How we verify

NCT03940768

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Use of Lactobacillus Plantarum 299v in Treatment of Cancer Patients Who Received Home Enteral Nutrition

Completed NA Last updated 30 March 2020

What this trial tests

NA trial testing Lactobacillus plantarum 299v in Cancer in 35 participants. Completed in 1 March 2020.

Timeline

10 May 2019

Primary endpoint
1 March 2020

1 March 2020

Quick facts

Lead sponsor	Medical University of Gdansk
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	35
Start date	10 May 2019
Primary completion	1 March 2020
Estimated completion	1 March 2020
Sites	1 location across Poland

Drugs / interventions tested

Lactobacillus plantarum 299v — full drug profile →
Placebo

Conditions studied

Cancer — all drugs for Cancer →

Sponsor

Medical University of Gdansk

Who can join

18 and older, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to assess the impact of Lactobacillus plantarum 299v on nutritional status, tolerance of enteral diet and the quality of life. Administration of this probiotic may potentially improve nutritional status and tolerance of enteral diet. It also may provide positive effect on quality of life.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

The use of Lactobacillus plantarum 299v (DSM 9843) in cancer patients receiving home enteral nutrition - study protocol for a randomized, double-blind, and placebo-controlled trial.
Kaźmierczak-Siedlecka K, Folwarski M, Skonieczna-Żydecka K, Ruszkowski J, et al · · 2020 · cited 24× · PMID 32917221 · DOI 10.1186/s12937-020-00598-w
The use of Lactobacillus plantarum 299v (DSM 9843) in cancer patients receiving home enteral nutrition – study protocol for a randomized, double-blind, and placebo-controlled trial
Karolina K, Folwarski M, Skonieczna-Żydecka K, Ruszkowski J, et al · · 2020 · DOI 10.21203/rs.2.23667/v3
Effects of 4 weeks of Lactobacillus plantarum 299v supplementation on nutritional status, enteral nutrition tolerance, and quality of life in cancer patients receiving home enteral nutrition – a double-blind, randomized, and placebo-controlled trial
Karolina K, Folwarski M, Ruszkowski J, Skonieczna-Żydecka K, et al · · 2020 · DOI 10.21203/rs.3.rs-22190/v1

Verify or expand the search:

Other trials of Lactobacillus plantarum 299v

Trials testing the same drug.

NCT07383701 — Lactiplantibacillus Plantarum 299v Probiotic Supplementation in Patients With Diabetic Macular Edema · Phase 2 · not yet recruiting

Other recruiting trials for Cancer

Currently open trials in the same condition.

NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting

Other Medical University of Gdansk trials

Trials by the same sponsor.

NCT07521280 — State-Based Rehabilitation for Youth Athletes With Osgood-Schlatter or Sever-Related Apophyseal Pain · NA · not yet recruiting
NCT07446517 — Low-Level Laser Therapy for Osgood-Schlatter or Sever Pain in Youth Athletes · NA · recruiting
NCT07449585 — Pericapsular Nerve Group Block Versus Intrathecal Morphine for Analgesia After Total Hip Arthroplasty · NA · not yet recruiting
NCT07397208 — Assessment of the Repeatability of Sublingual Microcirculation Function Measurements in Healthy Volunteers and Criticall · not yet recruiting
NCT07345403 — GENECARD - the Use of Genetic, Epigenetic, Metabolomic, Proteomic and Microbiotic Markers, Image and Voice Biomarker Ana · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03940768 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Gdansk
Last refreshed: 30 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03940768.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing